BDBM698662 BDBM698663::BDBM698664::BDBM698665::US20240317721, Example 280a

SMILES Cc1c(c(nn1C1CC2(C1)CN(C2)C(=O)C=C)N1CC[C@@H](CN2CCN(C3COC3)C3COCC23)CC1(C)C)-c1c(Cl)c(Cl)cc2[nH]ncc12

InChI Key InChIKey=HMSDFQUOAPPJFI-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 698662   

TargetGTPase KRas [G12C](Human)
Novartis

US Patent
LigandPNGBDBM698662(BDBM698665 | BDBM698664 | US20240317721, Example 2...)
Affinity DataIC50: 5.00E+3nMAssay Description:Assays were run using 384-well plates (781207/Greiner) in which one column was designated as the high signal (no inhibition) control, and contained D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetGTPase KRas [G12C](Human)
Novartis

US Patent
LigandPNGBDBM698662(BDBM698665 | BDBM698664 | US20240317721, Example 2...)
Affinity DataIC50: 7nMAssay Description:Assays were run using 384-well plates (781207/Greiner) in which one column was designated as the high signal (no inhibition) control, and contained D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetGTPase KRas [G12C](Human)
Novartis

US Patent
LigandPNGBDBM698662(BDBM698665 | BDBM698664 | US20240317721, Example 2...)
Affinity DataIC50: 1.67E+3nMAssay Description:Assays were run using 384-well plates (781207/Greiner) in which one column was designated as the high signal (no inhibition) control, and contained D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

TargetGTPase KRas [G12C](Human)
Novartis

US Patent
LigandPNGBDBM698662(BDBM698665 | BDBM698664 | US20240317721, Example 2...)
Affinity DataIC50: 5nMAssay Description:Assays were run using 384-well plates (781207/Greiner) in which one column was designated as the high signal (no inhibition) control, and contained D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent